11
12
de la Court, J. R., Bruns, A. H.W., Roukens, A. H.E., Baas, I. O., van Steeg, K., Toren-Wielema, M. L., Tersmette, M., Blijlevens, N. M.A., Huis in ’t Veld, R. A.G., Wolfs, T. F.W., Tissing, W. J.E., Kyuchukova, Y., Heijmans, J.
Veröffentlicht in: de la Court , J R , Bruns , A H W , Roukens , A H E , Baas , I O , van Steeg , K , Toren-Wielema , M L , Tersmette , M , Blijlevens , N M A , Huis in ’t Veld , R A G , Wolfs , T F W , Tissing , W J E , Kyuchukova , Y & Heijmans , J 2022 , ' The Dutch Working Party on Antibiotic Policy (SWAB) Recommendations for the Diagnosis and Management of Febrile Neutropenia in Patients with Cancer ' , Infectious diseases and therapy , vol. 11 , pp. 2063–2098 . https://doi.org/10.1007/s40121-022-00700-1;
2022
Veröffentlicht in: de la Court , J R , Bruns , A H W , Roukens , A H E , Baas , I O , van Steeg , K , Toren-Wielema , M L , Tersmette , M , Blijlevens , N M A , Huis in ’t Veld , R A G , Wolfs , T F W , Tissing , W J E , Kyuchukova , Y & Heijmans , J 2022 , ' The Dutch Working Party on Antibiotic Policy (SWAB) Recommendations for the Diagnosis and Management of Febrile Neutropenia in Patients with Cancer ' , Infectious diseases and therapy , vol. 11 , pp. 2063–2098 . https://doi.org/10.1007/s40121-022-00700-1;
2022
13
Cruijsen, M, van der Velden, W J F M, de Haan, A F J, Klein, S K, Hoogendoorn, M, Tromp, Y, de Valk, B, van Rees, B, de Boer, F, van der Spek, E, Pruijt, J, Verdonck, L F, Vellenga, E, Blijlevens, N, van de Loosdrecht, A A, Huls, G
Veröffentlicht in: Cruijsen , M , van der Velden , W J F M , de Haan , A F J , Klein , S K , Hoogendoorn , M , Tromp , Y , de Valk , B , van Rees , B , de Boer , F , van der Spek , E , Pruijt , J , Verdonck , L F , Vellenga , E , Blijlevens , N , van de Loosdrecht , A A & Huls , G 2020 , ' Use of azacitidine and its safety and efficacy in daily clinical practice in The Netherlands : the OCEAN study ' , Leukemia & Lymphoma , vol. 61 , no. 11 , pp. 2752-2755 . https://doi.org/10.1080/10428194.2020.1775217;
2020
Veröffentlicht in: Cruijsen , M , van der Velden , W J F M , de Haan , A F J , Klein , S K , Hoogendoorn , M , Tromp , Y , de Valk , B , van Rees , B , de Boer , F , van der Spek , E , Pruijt , J , Verdonck , L F , Vellenga , E , Blijlevens , N , van de Loosdrecht , A A & Huls , G 2020 , ' Use of azacitidine and its safety and efficacy in daily clinical practice in The Netherlands : the OCEAN study ' , Leukemia & Lymphoma , vol. 61 , no. 11 , pp. 2752-2755 . https://doi.org/10.1080/10428194.2020.1775217;
2020